Osteopore Limited Stock

Equities

OSX

AU0000053324

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. 02:10:44 2024-04-26 am EDT 5-day change 1st Jan Change
0.4 AUD +17.65% Intraday chart for Osteopore Limited +321.05% -39.39%

Financials

Sales 2022 1.69M 1.24M 1.9M Sales 2023 2.22M 1.63M 2.49M Capitalization 6.82M 5.01M 7.66M
Net income 2022 -4M -2.94M -4.49M Net income 2023 -4M -2.94M -4.49M EV / Sales 2022 9.64 x
Net cash position 2022 1.27M 936K 1.43M Net cash position 2023 64.06K 47.09K 71.97K EV / Sales 2023 3.05 x
P/E ratio 2022
-4.42 x
P/E ratio 2023
-1.29 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 96.4%
More Fundamentals * Assessed data
Dynamic Chart
1 day+17.65%
1 week+321.05%
Current month+33.33%
1 month+515.38%
3 months-23.81%
6 months-47.71%
Current year-39.39%
More quotes
1 week
0.10
Extreme 0.096
0.55
1 month
0.08
Extreme 0.084
0.76
Current year
0.05
Extreme 0.053
0.76
1 year
0.05
Extreme 0.053
2.18
3 years
0.05
Extreme 0.053
8.25
5 years
0.05
Extreme 0.053
22.35
10 years
0.05
Extreme 0.053
22.35
More quotes
Managers TitleAgeSince
Chief Executive Officer - 14-11-30
Comptroller/Controller/Auditor - -
Corporate Secretary - 23-01-25
Members of the board TitleAgeSince
Chairman 49 21-07-31
Director/Board Member - 23-07-17
Director/Board Member - 19-06-23
More insiders
Date Price Change Volume
24-04-26 0.4 +17.65% 761 018
24-04-24 0.34 -13.92% 515,524
24-04-23 0.395 +139.39% 2,358,355
24-04-22 0.165 +73.68% 253,205
24-04-19 0.095 -20.83% 164,089

Delayed Quote Australian S.E., April 26, 2024 at 02:10 am EDT

More quotes
Osteopore Limited is an Australia-based medical technology company. The Company is engaged in commercializing a range of bespoke products specifically engineered to facilitate bone healing across multiple therapeutic areas. The Company’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through three-dimensional (3D) printing and bioresorbable material. The Company’s Osteoplug in plug and strip configuration fills craniotomy gaps effortlessly. It also promotes bone tissue integration, from the skull to the bone flap. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. It also offers craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, minimally invasive skull base surgery, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, immediate implant loading, and more.
Calendar
More about the company